It would be nice if you could document that cost/pricing of either Toraymyxin or Cytosorb. If one had real prices, then it would be possible to do apples to apples comparisons. What is important is the cost of therapy. If cytosorb had to be used 7 times, then the cost is not $500 ( a figure never verified). Indeed the company said recently that they still have to conduct pricing studies, so we know that any cost comparisons are meaningless at this time.
Market Data 
Markets 
AI
